Effect of Cationic Liposomes on Intracellular Trafficking and Efficacy of Antisense Oligonucleotides in Mouse Peritoneal Macrophages

References

• Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y. M., Dietzschold B., Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 1996; 93: 2448–2453
   PubMed Web of Science ®Google Scholar
• Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 1990; 215: 403–410
   PubMed Web of Science ®Google Scholar
• Arima H., Sakamoto T., Aramaki Y., Ishidate K., Tsuchiya S. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides. J. Pharm. Sci. 1997; 86: 1079–1084
   PubMed Web of Science ®Google Scholar
• Bennett C. F., Chiang M.-Y., Chan H., Shoemaker J. E.E., Mirabelli C. K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 1992; 41: 1023–1033
   PubMed Web of Science ®Google Scholar
• Bennett C. F. Intracellular delivery of oligonucleotides with cationic liposomes. Delivery Strategies for Antisense Oligonucleotide Therapeutics, S. Akhtar. CRC Press, Boca Raton, FL 1995; 223–232
   Google Scholar
• Bielinska A., Kukowska-Latallo J. F., Johnson J., Tomalia D. A., Baker J.R., Jr. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996; 24: 2176–2182
   PubMed Web of Science ®Google Scholar
• Bilecki W., Okruszek A., Przewlocki R. The effect of antisense oligonucleotides on nitric oxide secretion from macrophage-like cells. Antisense Nucleic Acid Drug Dev. 1997; 7: 531–537
   PubMedGoogle Scholar
• Bishop M. R., Iversen P. L., Bayever E., Sharp J. G., Greiner T. C., Copple B. L., Ruddon R., Zon G., Arneson M., Armitage J. O., Kessinger A. Phase I trial of antisense oligonucleotide OL(1)p53 in hematologic malignancies. J. Clin. Oncol. 1996; 14: 1320–1326
   PubMed Web of Science ®Google Scholar
• Boussif O., Lezoualc'h F., Zanta M. A., Mergny M. D., Scherman D., Demeneix B., Behr J. P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 1995; 92: 7297–7301
   PubMed Web of Science ®Google Scholar
• Burgess T. L., Fisher E. F., Ross S. L., Bready J. V., Qian Y.-X., Baycwitch L. A., Cohen A. M., Herrera C. J., Hu S. S.-F., Kramer T. B., Lott F. D., Martin F. H., Pierce G. F., Simonet L., Farrell C. L. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 1995; 92: 4051–4055
   PubMed Web of Science ®Google Scholar
• Chiang M.-Y., Chan H., Zounes M. A., Freier S. M., Lima W. F., Bennett C. F. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 1991; 266(18)162–18; 171
   Google Scholar
• Dclong R., Stephenson K., Loftus T., Fisher M., Alahari S., Nolting A., Juliano R. L. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. J. Pharm. Sci. 1997; 86: 762–764
   PubMed Web of Science ®Google Scholar
• Ding M., Zhang M., Wong J. L., Vorkuhl R. R., Ellison G. W. Antisense blockade of inducible nitric oxide synthase in glial cells derived from adult SJL mice. Neurosci. Lett 1996; 220: 89–92
   PubMed Web of Science ®Google Scholar
• Filion M. C., Phillips N. C. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1997; 1329: 345–356
   PubMed Web of Science ®Google Scholar
• Kanamaru T., Takagi T., Takakura Y., Hashida M. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes. J. Drug Targeting 1998; 5: 235–246
   PubMed Web of Science ®Google Scholar
• Knowles R. G., Salter M., Brooks S. L., Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 1990; 172: 1042–1048
   PubMed Web of Science ®Google Scholar
• Leonetti J. P., Degols G., Lebleu B. Biological activity of oligonucleotide-poly(L-lysine) conjugate: mechanism of cell uptake. Bioconjugate Chem. 1990; 1: 149–153
   PubMed Web of Science ®Google Scholar
• Litzinger D. C., Brown J. M., Wala I., Kaufman S. A., Van G. Y., Farrell C. L., Collins D. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim. Biophys. Acta 1996; 1281: 139–149
   PubMed Web of Science ®Google Scholar
• Liu S., Adcock I. M., Old R. W., Barnes P. J., Evans T. W. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 1993; 196: 1208–1213
   PubMed Web of Science ®Google Scholar
• MacMicking J. D., Nathan C., Horn G., Chartrain N., Fletcher D. S., Trumbauer M., Stevens K., Xie Q.-W., Sokol K., Hutchinson N., Chen H., Mudgett J. S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81: 641–650
   PubMed Web of Science ®Google Scholar
• Marcusson E. G., Bhat B., Manoharan M., Bennett C. F., Dean N. M. Phosphorothioate oligonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res. 1998; 26: 2016–2023
   PubMed Web of Science ®Google Scholar
• Moncada S., Palmer R. M.J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Nathan C., Xie Q.-W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915–918
   PubMed Web of Science ®Google Scholar
• Noiri E., Peresleni T., Miller F., Goligorsky M. S. In vivo targeting of inducible NO synthase with oligonucleotides protects rat kidney against ischemia. J. Clin. Invest. 1996; 97: 2377–2383
   PubMed Web of Science ®Google Scholar
• Oberhauser B., Plank C., Wagner E. Enhancing endosomal exit of nucleic acids using pH-sensitive viral fusion peptides. Delivery Strategies for Antisense Oligonucleotide Therapeutics, S. Akhtar. CRC Press, Boca Raton, FL 1995; 247–266
   Google Scholar
• Peresleni T., Noiri E., Bahou W. F., Goligorsky M. S. Antisense oligonucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am. J. Physiol. 1996; 270: F971–F977
   PubMed Web of Science ®Google Scholar
• Ropert C., Couvreur P., Malvy C. The delivery of oligonucleotides using pH sensitive liposomes. Delivery Strategies for Antisense Oligonucleotide Therapeutics, S. Akhtar. CRC Press, Boca Raton, FL 1995; 233–245
   Google Scholar
• Taylor M. F., Paulauskis J. D., Weller D. D., Kobzik L. Comparison of efficacy of antisense oligomer directed toward TNF-α in helper T and macrophage cell lines. Cytokine 1997; 9: 672–681
   PubMed Web of Science ®Google Scholar
• Thomae K. R., Geller D. A., Billiar T. R., Davies P., Pitt B. R., Simmons R. L., Nakayama D. K. Antisense oligonucleotide to inducible nitric oxide synthase inhibits nitric oxide synthesis in rat pulmonary artery smooth muscle cells in culture. Surgery 1993; 114: 272–277
   PubMed Web of Science ®Google Scholar
• Webb A., Cunningham D., Cotter F., Clarke P. A., Stefano F. D., Ross P., Corbo M., Dziewanowska Z. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 1997; 349: 1137–1141
   PubMed Web of Science ®Google Scholar
• Xie Q.-W., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225–228
   PubMed Web of Science ®Google Scholar
• Yaswen P., Stampfer M. R., Ghosh K., Cohen J. S. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 1993; 3: 67–77
   PubMedGoogle Scholar
• Zelphati O., Szoka F.C., Jr. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?. J. Control. Release 1996; 41: 99–119
   Web of Science ®Google Scholar